In cases of CHH, the absence of the gonadotropin and sex steroid surge is a hallmark feature [18]
Technique is important too
As a modified fragment of human growth hormone (hGH), this peptide focuses on fat metabolism without the typical side effects associated with full hGH therapy, such as insulin resistance or increased IGF-1 levels
If you have certain stomach or intestinal conditions If you have atrophic gastritis, celiac disease, Crohns disease, or have had stomach or intestinal surgery, its possible youre not able to properly absorb vitamin B12 from foods and need to use dietary supplements to meet your daily intake needs
By inhibiting NNMT, 5-Amino-1MQ increases cellular SAM and NAD+ levels, enhances NAD+ salvage pathway flux, activates SIRT-1, boosts oxidative phosphorylation (OXPHOS), and influences cellular energy homeostasis and epigenetic modifications

Standard titration schedule from trials 12-week escalation protocol: Weeks 1-4: 0.6mg weekly Initiation dose Body adapts to amylin effects Minimal side effects at this level Weight loss begins (modest) Weeks 5-8: 1.2mg weekly First dose increase (doubling) Gastric slowing becomes more noticeable Appetite suppression strengthens Accelerated weight loss Weeks 9-12: 1.8mg weekly Second increase Strong satiety effects More pronounced GI effects possible Approaching maximum efficacy Week 13+: 2.4mg weekly (maintenance) Target therapeutic dose Maximum weight loss velocity Maintained indefinitely Nausea typically resolved by this point (adapted) Why this schedule works: Gradual exposure reduces side effects 4-week intervals allow full adaptation Doubling steps (0.61.22.4) are tolerable Proven in hundreds of patients Balances speed with tolerability Use our peptide calculator and peptide dosing guide at SeekPeptides for precise calculations